000			02163 a2200565 4500
005			20250514060035.0
264		0	_c20030310
008			200303s 0 0 eng d
022			_a0006-2952
024	7		_a10.1016/s0006-2952(02)01568-x _2doi
040			_aNLM _beng _cNLM
100	1		_aMartin, Sophie
245	0	0	_aDelphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2. _h[electronic resource]
260			_bBiochemical pharmacology _cFeb 2003
300			_a669-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnthocyanins _xpharmacology
650	0	4	_aCattle
650	0	4	_aCaveolin 1
650	0	4	_aCaveolins _xmetabolism
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCyclin D1 _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclins _xmetabolism
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aEndothelial Growth Factors _xpharmacology
650	0	4	_aEndothelium, Vascular _xcytology
650	0	4	_aEnzyme Activation _xdrug effects
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aImmune Sera _xpharmacology
650	0	4	_aIntercellular Signaling Peptides and Proteins _xpharmacology
650	0	4	_aLymphokines _xpharmacology
650	0	4	_aMitogen-Activated Protein Kinase 1 _xmetabolism
650	0	4	_aMitogen-Activated Protein Kinase 3
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aS Phase _xdrug effects
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
650	0	4	_aras Proteins _xmetabolism
700	1		_aFavot, Laure
700	1		_aMatz, Rachel
700	1		_aLugnier, Claire
700	1		_aAndriantsitohaina, Ramaroson
773	0		_tBiochemical pharmacology _gvol. 65 _gno. 4 _gp. 669-75
856	4	0	_uhttps://doi.org/10.1016/s0006-2952(02)01568-x _zAvailable from publisher's website
999			_c12364410 _d12364410